Related Experiment Video
Updated: Dec 7, 2025
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
TGIF1-Twist1 axis in pancreatic ductal adenocarcinoma
Mohammed S Razzaque1, Azeddine Atfi2
1Department of Pathology, Lake Erie College of Osteopathic Medicine, Erie, PA, USA.
Abstract:
TG-interacting factor 1 (TGIF1) exerts inhibitory effects on transforming growth factor-beta (TGF-β) signaling by suppressing Smad signaling pathway at multiple levels. TGIF1 activity is important for normal embryogenesis and organogenesis, yet its dysregulation can culminate in tumorigenesis. For instance, increased expression of TGIF1 correlates with poor prognosis in triple-negative breast cancer patients, and enforced expression of TGIF1 facilitates Wnt-driven mammary tumorigenesis, suggesting that TGIF1 might function as an oncoprotein. Quite surprisingly, TGIF1 has recently been shown to function as a tumor suppressor in pancreatic ductal adenocarcinoma (PDAC), possibly owing to its ability to antagonize the pro-malignant transcription factor Twist1. In this article, we will briefly elaborate on the biological and clinical significance of the unique tumor-suppressive function of TGIF1 and its functional interaction with Twist1 in the context of PDAC pathogenesis and progression.
Insights
TG-interacting factor 1 (TGIF1) uniquely suppresses pancreatic cancer by antagonizing the Twist1 transcription factor. This contrasts with its oncogenic role in breast cancer, highlighting context-dependent functions.
Area of Science:
- Molecular Biology
- Cancer Research
- Developmental Biology
Background:
- TG-interacting factor 1 (TGIF1) inhibits transforming growth factor-beta (TGF-β) signaling via the Smad pathway.
- TGIF1 dysregulation is linked to tumorigenesis, acting as an oncoprotein in breast cancer.
- Recent findings suggest TGIF1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma (PDAC).
Purpose of the Study:
- To elaborate on TGIF1's tumor-suppressive role in PDAC.
- To investigate TGIF1's interaction with Twist1 in PDAC.
- To understand the biological and clinical significance of TGIF1 in PDAC.
Main Methods:
- Literature review and analysis of existing research on TGIF1.
- Examination of TGIF1's molecular mechanisms in PDAC.
- Exploration of TGIF1's functional interplay with Twist1.
Main Results:
- TGIF1 antagonizes the pro-malignant transcription factor Twist1 in PDAC.
- TGIF1 exhibits context-dependent roles, acting as a tumor suppressor in PDAC but an oncoprotein in breast cancer.
- TGIF1's interaction with Twist1 is crucial for its tumor-suppressive function in PDAC.
Conclusions:
- TGIF1 possesses a unique tumor-suppressive function in pancreatic ductal adenocarcinoma.
- The antagonism between TGIF1 and Twist1 is key to TGIF1's tumor-suppressive activity in PDAC.
- Understanding TGIF1's dual role is vital for PDAC pathogenesis and therapeutic strategies.
